iBio is a leading biotechnology company based in Newark, DE, specializing in AI-powered precision antibody therapeutics and cancer immunotherapies. With their cutting-edge discovery platform, they offer precision antibody identification and optimization, as well as innovative technologies for antibody masking and bispecific optimization. Their robust immuno-oncology pipeline and expertise in AI drug discovery make them a key player in the field.
Driven by a team of experts in platform technology, machine learning, and research development, iBio is dedicated to advancing hard-to-engineer antibodies and accelerating drug discovery through AI and machine learning. With a focus on developing high-value pipeline assets, iBio is committed to revolutionizing the field of biotechnology and making significant contributions to the field of precision medicine.
Generated from the website